|
|
|||||||||||
The British Journal of Psychiatry 128: 451-455 (1976)
© 1976 The Royal College of Psychiatrists
P Andrews, JN Hall and RP Snaith
Phenothiazine drugs were withdrawn from 17 chronic schizophrenic in- patients, with a control group of 14 patients remaining on active medication. The trial was conducted under double blind conditions over a period of 42 weeks with weekly assessment of the patients by ward nurses. Of the placebo group 35% relapsed, relapse being related to the level of previous active medication.
This article has been cited by other articles:
![]() |
N. L. Sohler, J. Walkup, D. McAlpine, C. Boyer, and M. Olfson Antipsychotic Dosage at Hospital Discharge and Outcomes Among Persons With Schizophrenia Psychiatr Serv, September 1, 2003; 54(9): 1258 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.W.A. Browne, S.J. Cooper, R. Wilson, and D.J. King Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients J Psychopharmacol, January 1, 1988; 2(2): 94 - 103. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |